Roflumilast has the potential to be used in a large segment of the COPD population. COPD is one of the leading causes of morbidity and mortality, occurring in approximately 10% of the population in ...

IN recent years interest in pulmonary embolization has centered largely about preventive measures, with emphasis on leg-vein ligation and anticoagulant therapy. 1,2 The principal cause for concern has ...

A recent "Symposium on Frontiers of Pulmonary Radiology" in Boston, dedicated to Felix G. Fleischner, was a fitting tribute to a man who, for many years, has made incalculable contributions to ...

A new study in The American Journal of Pathology details a novel rat model that closely replicates the pathological features and physiological changes associated with human chronic obstructive ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...